Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07022990 · ClinicalTrials.gov registry record · NA

Improving Medication Management in World Trade Center Responders

A NA study of Polypharmacy, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07022990 is a NA study of Polypharmacy that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 50 participants, below the 1,595-participant average among 8 other Polypharmacy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07022990, a NA study of Polypharmacy, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.

Conditions Studied

Polypharmacy

Interventions

  • OTHER Educational brochure for deprescribing

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-04-08
Est. Completion 2026-06-30
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07022990

The ClinicalTrials.gov registry entry for NCT07022990 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,595-participant average among 8 other Polypharmacy trials with a reported enrollment target (97% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Educational brochure for deprescribing is the first listed.

NCT07022990 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07022990 about?

NCT07022990 is a clinical study titled "Improving Medication Management in World Trade Center Responders". By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to invest...

What is the current status of trial NCT07022990?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-08. Estimated completion is 2026-06-30.

What conditions does trial NCT07022990 study?

This clinical trial studies the following conditions: Polypharmacy.

What interventions are being tested in trial NCT07022990?

The interventions under investigation include: Educational brochure for deprescribing (OTHER).

Who is sponsoring clinical trial NCT07022990?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07022990 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Polypharmacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Polypharmacy

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.